02Product Overview
RAPROS® is an orally administered prostacyclin derivative which acts by binding to prostacyclin receptors.
-
- Ingredients and quantities
- Each tablet contains 55μg of beraprost sodium
-
- Indications
- In cats with IRIS* Stage II-III CKD:
Suppression of deterioration of renal function and improvement of clinical signs - *IRIS: International Renal Interest Society
-
- Dosage and method of administration
- Orally administer 1 tablet per cat, twice a day after feeding
Small, easy-to-give tablet
(diameter: 6.0㎜)
Veterinarians and owners have found therapeutic effects of RAPROS® to be highly satisfactory.
-
- Assessment of overall improvement by veterinarian
-
- Assessment of QOL by owner
